AHW-59825-79954
3 vaccinations
2 coded responses
33 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Pre-eclampsia, Pregnancy — Feeling: GoodFree text: Preeclampsia with pregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-28
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Asthenia, Breakthrough COVID-19, Fatigue, Nasal congestion, Sinus congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Diagnosed with breakthrough COVID infection. Had symptoms of weakness, fatigue, nasal and sinus congestion.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-29
- 2022-09-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Preeclampsia with pregnancy
Release 10 — 3 months, dose 3
Symptoms: Diagnosed with breakthrough COVID infection. Had symptoms of weakness, fatigue, nasal and sinus congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-eclampsia | ✓ | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release